Reprogramming Daptomycin and A54145 Biosynthesis to Produce Novel Lipopeptide Antibiotics
Authors:
- 13 September 2010
- book chapter
- Published by Wiley
- p. 285-308
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Development of a Genetic System for Combinatorial Biosynthesis of Lipopeptides in Streptomyces fradiae and Heterologous Expression of the A54145 Biosynthesis Gene ClusterApplied and Environmental Microbiology, 2010
- Genetically Engineered Lipopeptide Antibiotics Related to A54145 and Daptomycin with Improved PropertiesAntimicrobial Agents and Chemotherapy, 2010
- Daptomycin: mechanisms of action and resistance, and biosynthetic engineeringCurrent Opinion in Chemical Biology, 2009
- Dynamic thiolation–thioesterase structure of a non-ribosomal peptide synthetaseNature, 2008
- Phylogenetic analysis of condensation domains in NRPS sheds light on their functional evolutionBMC Ecology and Evolution, 2007
- Structural Characterization of Daptomycin Analogues A21978C1-3(d-Asn11) Produced by a Recombinant Streptomyces roseosporus StrainJournal of Natural Products, 2007
- Combinatorial biosynthesis of novel antibiotics related to daptomycinProceedings of the National Academy of Sciences, 2006
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Assembly-Line Enzymology for Polyketide and Nonribosomal Peptide Antibiotics: Logic, Machinery, and MechanismsChemical Reviews, 2006
- Heterologous production of daptomycin in Streptomyces lividansJournal of Industrial Microbiology and Biotechnology, 2005